Correspondence of Pubertal Neuroendocrine and Tanner Stage Changes in Boys and Associations With Substance Use.
Journal
Child development
ISSN: 1467-8624
Titre abrégé: Child Dev
Pays: United States
ID NLM: 0372725
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
pubmed:
1
6
2018
medline:
2
6
2020
entrez:
1
6
2018
Statut:
ppublish
Résumé
This study examined correspondence between timing (onset) and tempo (rate) of sexual maturation prospectively (average ages 11-16 years) measured by gonadal hormones and secondary sex characteristics (Tanner stage) using dual-process models, and associations of these measures with substance use (SU) involvement in boys at age 16 years (N = 534, 77.5% White/22.5% Non-White). All measures of timing were highly associated. Early Tanner stage timing often predicted slower increases in gonadal steroids, but not the reverse; patterns varied by ethnicity. Hormone and Tanner stage measures were similar earlier in development but diverged later in development. In White boys only, early timing of the pubertal rise in testosterone was associated with increased SU involvement, suggesting a physiological rather than psychosocial mechanism of association.
Identifiants
pubmed: 29851020
doi: 10.1111/cdev.13101
pmc: PMC6274631
mid: NIHMS968627
doi:
Substances chimiques
Gonadal Steroid Hormones
0
Testosterone
3XMK78S47O
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e763-e782Subventions
Organisme : NIDA NIH HHS
ID : K01 DA039288
Pays : United States
Organisme : NIDA NIH HHS
ID : K05 DA031248
Pays : United States
Organisme : NIDA NIH HHS
ID : P50 DA005605
Pays : United States
Informations de copyright
© 2018 Society for Research in Child Development.
Références
J Youth Adolesc. 2015 Sep;44(9):1720-34
pubmed: 26208832
Addiction. 2013 Mar;108(3):487-96
pubmed: 23163243
Horm Res. 2002;57 Suppl 2:2-14
pubmed: 12065920
J Neurosci. 2015 May 6;35(18):7226-38
pubmed: 25948271
J Abnorm Psychol. 2013 Aug;122(3):782-96
pubmed: 24016016
J Clin Endocrinol Metab. 1980 Oct;51(4):925-9
pubmed: 6448262
J Pediatr Endocrinol Metab. 2015 Mar;28(3-4):367-74
pubmed: 25210751
Child Dev. 2009 Mar-Apr;80(2):327-37
pubmed: 19466995
Dev Psychol. 2014 Dec;50(12):2715-26
pubmed: 25437757
Mol Cell Endocrinol. 2006 Jul 25;254-255:154-62
pubmed: 16765510
Addiction. 2013 Oct;108(10):1845-54
pubmed: 23680010
Brain Cogn. 2010 Feb;72(1):66-72
pubmed: 19942334
Dev Rev. 2007 Jun;27(2):151-171
pubmed: 20740062
Drug Alcohol Depend. 1999 Jun 1;55(1-2):165-76
pubmed: 10402161
Arch Pediatr Adolesc Med. 2010 Feb;164(2):166-73
pubmed: 20124146
Pediatrics. 2016 Jul;138(1):
pubmed: 27279647
Addict Disord Their Treat. 2016 Jun;15(2):61-73
pubmed: 27199616
Dev Psychol. 2010 Sep;46(5):1341-53
pubmed: 20822243
Horm Behav. 2013 Feb;63(2):392-7
pubmed: 23229027
J Adolesc Health. 2017 Jul;61(1):53-60
pubmed: 28215580
Endocrinology. 1990 Feb;126(2):1165-72
pubmed: 2298157
Child Dev. 1987 Jun;58(3):829-41
pubmed: 3608653
Eur J Endocrinol. 2012 Dec 31;168(2):129-36
pubmed: 23093700
Psychol Addict Behav. 2006 Dec;20(4):404-14
pubmed: 17176175
Psychol Addict Behav. 2002 Dec;16(4):290-8
pubmed: 12503901
J Res Adolesc. 2015 Jun 1;25(2):201-213
pubmed: 26146470
Psychol Bull. 2017 Sep;143(9):903-938
pubmed: 28530427
J Am Acad Child Adolesc Psychiatry. 2010 Dec;49(12):1189-201; quiz 1285
pubmed: 21093769
J Adolesc. 2002 Oct;25(5):535-50
pubmed: 12234559
Addict Behav. 2006 Apr;31(4):686-96
pubmed: 15964148
Semin Reprod Med. 2004 Nov;22(4):337-47
pubmed: 15635501
J Abnorm Psychol. 2012 Feb;121(1):73-87
pubmed: 21668078
Dev Psychol. 2014 Jun;50(6):1734-45
pubmed: 24588522
Dev Psychol. 2011 Sep;47(5):1389-1409
pubmed: 21639623
Front Neuroendocrinol. 2017 Jan;44:122-137
pubmed: 28007528